Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 7/20 | 0.45 |
| ▸ | HTR4 | Q13639 | 7/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 3/20 | 0.37 |
| ▸ | DRD2 | P14416 | 3/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PKLR | P30613 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1728203 | 0.90 | HTR3A (0.44) | HTR3AHTR4PARP1 | |
| SCHEMBL1726873 | 0.90 | HTR4 (0.48) | HTR3AHTR4CYP2C9CYP2C19HTR2A | |
| SCHEMBL828636 | 0.88 | HTR3A (0.59) | HTR3AHTR4PARP1 | |
| SCHEMBL29401326 | 0.88 | HTR3A (0.59) | HTR3AHTR4PARP1 | |
| SCHEMBL1728189 | 0.78 | HTR4 (0.59) | HTR3AHTR4HTR2AHTR2CPARP1 | |
| SCHEMBL829163 | 0.78 | HTR4 (0.60) | HTR3AHTR4PARP1 | |
| SCHEMBL29399928 | 0.78 | HTR4 (0.60) | HTR3AHTR4PARP1 | |
| SCHEMBL828465 | 0.76 | HTR3A (0.58) | HTR3AHTR4PARP1 | |
| SCHEMBL29400942 | 0.76 | HTR3A (0.58) | HTR3AHTR4PARP1 | |
| SCHEMBL829424 | 0.75 | HTR4 (0.76) | HTR3AHTR4PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1899324-B1 | Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists | THERAVANCE INC (US) | 2011-11-30 | — | — | EP | claimed |